Importantly, to our knowledge, this is the first study to simultaneously investigate both PDL1 and DLL3 biomarkers in endobronchial biopsies while exploring their correlation with clinical characteristics and overall survival in SCLC patients. Here, CD274 is linked to small cell lung carcinoma.